216 related articles for article (PubMed ID: 8018410)
1. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
[TBL] [Abstract][Full Text] [Related]
2. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
3. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.
Salari H; Dryden P; Davenport R; Howard S; Jones K; Bittman R
Biochim Biophys Acta; 1992 Feb; 1134(1):81-8. PubMed ID: 1543759
[TBL] [Abstract][Full Text] [Related]
5. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells.
Shoji M; Raynor RL; Fleer EA; Eibl H; Vogler WR; Kuo JF
Lipids; 1991 Feb; 26(2):145-9. PubMed ID: 2051897
[TBL] [Abstract][Full Text] [Related]
6. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
7. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
[TBL] [Abstract][Full Text] [Related]
9. Ether lipids inhibit the effects of phorbol diester tumor promoters.
Daniel LW; Etkin LA; Morrison BT; Parker J; Morris-Natschke S; Surles JR; Piantadosi C
Lipids; 1987 Nov; 22(11):851-5. PubMed ID: 3444377
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells.
Heesbeen EC; Verdonck LF; Staal GE; Rijksen G
Biochem Pharmacol; 1994 Apr; 47(9):1481-8. PubMed ID: 8185658
[TBL] [Abstract][Full Text] [Related]
11. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
Fleer EA; Berkovic D; Grunwald U; Hiddemann W
Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
[TBL] [Abstract][Full Text] [Related]
12. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines.
Wang YZ; Chang YB; Xing C; Fu D
Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183
[TBL] [Abstract][Full Text] [Related]
13. Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation of human leukemia HL60 and KG-1 cells.
Shoji M; Raynor RL; Berdel WE; Vogler WR; Kuo JF
Cancer Res; 1988 Dec; 48(23):6669-73. PubMed ID: 3180076
[TBL] [Abstract][Full Text] [Related]
14. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
[TBL] [Abstract][Full Text] [Related]
15. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity.
Uberall F; Oberhuber H; Maly K; Zaknun J; Demuth L; Grunicke HH
Cancer Res; 1991 Feb; 51(3):807-12. PubMed ID: 1846318
[TBL] [Abstract][Full Text] [Related]
16. Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha.
Aroca JD; Sánchez-Piñera P; Corbalán-García S; Conesa-Zamora P; de Godos A; Gómez-Fernández JC
Eur J Biochem; 2001 Dec; 268(24):6369-78. PubMed ID: 11737191
[TBL] [Abstract][Full Text] [Related]
17. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
18. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C is not involved in cholesterol-induced resistance to synthetic ether lipids.
Diomede L; Salmona M; Lamorte G; Piovani B; Sozzani S
Anticancer Res; 1993; 13(5A):1331-4. PubMed ID: 8239503
[TBL] [Abstract][Full Text] [Related]
20. The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine.
Boggs K; Rock CO; Jackowski S
Biochim Biophys Acta; 1998 Jan; 1389(1):1-12. PubMed ID: 9443598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
